Compounds > cotinine

cotinine and Parkinsonian Disorders

cotinine has been researched along with Parkinsonian Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campos, C; Grady, SR; Quik, M1
Grady, SR; Hrachova, M; Huang, LZ; Mallela, A; McIntosh, JM; Park, KM; Quik, M1
Dumery, B; Hirsch, E; Marchand, V; Parain, K1
Hermida-Ameijeiras, A; Labandeira-García, JL; López-Real, AM; Méndez-Alvarez, E; Soto-Otero, R1

Other Studies

4 other study(ies) available for cotinine and Parkinsonian Disorders

ArticleYear
Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice.
    Biochemical pharmacology, 2013, Oct-15, Volume: 86, Issue:8

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Central Nervous System; Cotinine; Dopamine; Dyskinesias; Mice; Mice, Knockout; Nicotine; Parkinsonian Disorders; Receptors, Nicotinic; Saccharin

2013
Role for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice.
    Neuropharmacology, 2012, Volume: 63, Issue:3

    Topics: Animals; Antiparkinson Agents; Autoradiography; Benserazide; Cotinine; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Hydroxydopamines; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nicotinic Agonists; Parkinsonian Disorders; Receptors, Nicotinic

2012
Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice.
    Brain research, 2001, Feb-02, Volume: 890, Issue:2

    Topics: Animals; Axons; Cotinine; Dopamine; Male; Mice; Mice, Inbred C57BL; Neostriatum; Nerve Degeneration; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Parkinsonian Disorders; Substantia Nigra; Tyrosine 3-Monooxygenase

2001
Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease.
    Biochemical pharmacology, 2002, Jul-01, Volume: 64, Issue:1

    Topics: Adrenergic Agents; Analysis of Variance; Animals; Corpus Striatum; Cotinine; Disease Models, Animal; Drug Interactions; Female; Male; Neurotoxicity Syndromes; Nicotine; Nicotinic Agonists; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley

2002